Initial clinical results of simultaneous 18F-FDG PET/MRI in comparison to 18F-FDG PET/CT in patients with head and neck cancer

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 41, Issue 4, 2014, Pages 639-648

  Kubiessa, K ^a   Purz, S ^a   Gawlitza, M ^a   Kuhn A ^a   Fuchs, J ^a   Steinhoff, K G ^a   Boehm, A ^a   Sabri, O ^a   Kluge, R ^a   Kahn, T ^a   Stumpp, P ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Head and neck cancer; PET CT; Simultaneous PET MRI

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; GADOBUTROL; IOMEPROL; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SCINTISCANNING; CANCER STAGING; CANCER SURGERY; CERVICAL LYMPH NODE; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COLLIMATOR; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; IMAGING SYSTEM; INTERMETHOD COMPARISON; LARYNX CARCINOMA; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MEDIASTINUM LYMPH NODE; METASTASIS; MICROINJECTOR; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OROPHARYNX CARCINOMA; PET SCANNER; PET-CT SCANNER; PET-MRI SCANNER; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; THORAX WALL METASTASIS; TONGUE CARCINOMA; TONSIL CARCINOMA; WHOLE BODY PET; WHOLE BODY SCINTISCANNING; COMPARATIVE STUDY; DIAGNOSTIC USE; EVALUATION STUDY; HEAD AND NECK NEOPLASMS; MULTIMODAL IMAGING; RADIOGRAPHY; SCINTISCANNING;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84897025552     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-013-2633-2     Document Type: Article

References (19)

1. Wippold FJ. Head and neck imaging: the role of CT and MRI. J Magn Reson Imaging 2007;25:453-65.
2. de Bondt RBJ, Nelemans PJ, Bakers F, Casselman JW, Peutz-Kootstra C, Kremer B, et al. Morphological MRI criteria improve the detection of lymph node metastases in head and neck squamous cell carcinoma: multivariate logistic regression analysis of MRI features of cervical lymph nodes. Eur Radiol 2009;19:626-33.
3. Castelijns JA, van den Brekel MWM. Imaging of lymphadenopathy in the neck. Eur Radiol 2002;12:727-38. (Pubitemid 36940125)
4. Nakamura T, Sumi M. Nodal imaging in the neck: recent advances in US, CT and MR imaging of metastatic nodes. Eur Radiol 2007;17:1235-41. (Pubitemid 46691953)
5. Yoon DY, Hwang HS, Chang SK, Rho YS, Ahn HY, Kim JH, et al. CT, MR, US,18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Eur Radiol 2009;19:634-42.
6. Ghanooni R, Delpierre I, Magremanne M, Vervaet C, Dumarey N, Remmelink M, et al. 18F-FDG PET/CTand MRI in the follow-up of head and neck squamous cell carcinoma. Contrast Media Mol Imaging 2011;6:260-6.
7. Beyer T, Freudenberg LS, Czernin J, Townsend DW. The future of hybrid imaging-part 3: PET/MR, small-animal imaging and beyond. Insights Imaging 2011;2:235-46.
8. Antoch G, Bockisch A. Combined PET/MRI: a new dimension in whole-body oncology imaging? Eur J Nucl Med Mol Imaging 2009;36 Suppl 1:S113-20.
9. Klinke T, Daboul A, Maron J, Gredes T, Puls R, Jaghsi A, et al. Artifacts in magnetic resonance imaging and computed tomography caused by dental materials. PLoS One 2012;7:e31766.
10. Castelijns JA. PET-MRI in the head and neck area: challenges and new directions. Eur Radiol 2011;21:2425-6.
11. Boss A, Stegger L, Bisdas S, Kolb A, Schwenzer N, Pfister M, et al. Feasibility of simultaneous PET/MR imaging in the head and upper neck area. Eur Radiol 2011;21:1439-46.
12. Platzek I, Beuthien-Baumann B, Schneider M, Gudziol V, Langner J, Schramm G, et al. PET/MRI in head and neck cancer: initial experience. Eur J Nucl Med Mol Imaging 2013;40:6-11.
13. Pearce T, Philip S, Brown J, Koh DM, Burn PR. Bone metastases from prostate, breast and multiple myeloma: differences in lesion conspicuity at short-tau inversion recovery and diffusion-weighted MRI. Br J Radiol 2012;85:1102-6.
14. Sommer G, Klarhöfer M, Lenz C, Scheffler K, Bongartz G, Winter L. Signal characteristics of focal bone marrow lesions in patients with multiple myeloma using whole body T1w-TSE, T2w-STIR and diffusion-weighted imaging with background suppression. Eur Radiol 2011;21:857-62.
15. Heusner T, Kuemmel S, Koeninger A, Hamami ME, Hahn S, Quinsten A, et al. Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for wholebody breast cancer staging. Eur J Nucl Med Mol Imaging 2010;37:1077-86.
16. Nakamoto Y, Tamai K, Saga T, Higashi T, Hara T, Suga T, et al. Clinical value of image fusion from MR and PET in patients with head and neck cancer. Mol Imaging Biol 2009;11:46-53.
17. Huang S, Chien C, Lin W, Fang FM, Wang PW, Lui CC, et al. A comparative study of fused FDG PET/MRI, PET/CT, MRI, and CT imaging for assessing surrounding tissue invasion of advanced buccal squamous cell carcinoma. Clin Nucl Med 2011;36:518-25.
18. Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med 2004;45:1519-27. (Pubitemid 47618506)
19. Guenzel T, Franzen A, Wiegand S, Kraetschmer S, Jahn JL, Mironczuk R, et al. The value of PETcompared to MRI in malignant head and neck tumors. Anticancer Res 2013;33:1141-6.